Last Trade: Bid: 0.0000 Last Size: 0 Ask: 0.0000 Trade Time: Bid x Ask Size: Change: +0.0000 (+0.00%) Day's Range: 0.00 - 0.00 Prev Close: 0.0000 52wk Range: 0.00 - 0.00 Open: 0.0000 P/E (ttm): Volume: 0 EPS (ttm):

Dermisonics, Inc., a development stage company, engages in the development of ultrasonic transdermal drug-delivery technologies. It primarily focuses on the development, testing, and commercialization of its active transdermal patch, called the U-Strip, that has been designed to facilitate the needle-free delivery of drugs with large molecular structures, such as Insulin into the bloodstream. This system is based on a radical integration of microelectronics and ultrasonic science with a product-carrying patch. Dermisonics also developed other portable ultrasonic systems, including the U-Wand and A-Wand systems for applications in the skin care and medical fields, respectively. The A-Wand is a hand held, portable, ultrasonic wand device for applying antiseptic solutions to cuts, abrasions, and wounds with a replaceable Patch-Cap, which holds up to 40 ml of antiseptic cream. The U-Wand is an ultrasonic cosmetic applicator device that is used to apply skin care compounds topically to the surface of the skin. The company was founded in 2000 and was formerly known as Second Stage Ventures, Inc. It changed its name to Dermisonics, Inc. in 2004. Dermisonics is based in Irvine, California.

MarketByte LLC has been paid a fee of $30,000 by Dermisonics for coverage of the company. In addition, Trilogy Capital Partners has assigned MarketByte LLC 285,000 warrants, convertible currently into restricted shares, at an exercise price of $.72, for coverage of Dermisonics.